-
Product Insights
NewLysosomal Alpha Glucosidase – Drugs In Development, 2024
The Lysosomal Alpha Glucosidase pipeline drugs market research report outlays comprehensive information on the Lysosomal Alpha Glucosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Pompe Disease, and Lafora Disease (Unverricht Disease). It also reviews key players involved in Lysosomal Alpha Glucosidase targeted therapeutics development with respective...
-
Product Insights
NewCyclin Dependent Like Kinase 5 – Drugs In Development, 2024
The Cyclin Dependent Like Kinase 5 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Like Kinase 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Oncology, and Genetic Disorders which include indications of Alzheimer's Disease, Parkinson's Disease, Coronavirus Disease 2019 (COVID-19), Breast Cancer, Ovarian Cancer, and Polycystic Kidney...
-
Product Insights
NewT Lymphocyte Activation Antigen CD86 – Drugs In Development, 2024
The T Lymphocyte Activation Antigen CD86 pipeline drugs market research report outlays comprehensive information on the T Lymphocyte Activation Antigen CD86 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Infectious Disease, Oncology, and Central Nervous System which include indications of Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Infectious Disease, Coronavirus Disease 2019 (COVID-19), Oncology, Melanoma, Alzheimer's...
-
Product Insights
NewCysteinyl Leukotriene Receptor 1 – Drugs In Development, 2024
The Cysteinyl Leukotriene Receptor 1 pipeline drugs market research report outlays comprehensive information on the Cysteinyl Leukotriene Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Gastrointestinal, and Infectious Disease which include indications of Asthma, Allergic Rhinitis, Alzheimer's Disease, Parkinson's Disease, Hemorrhoids, Coronavirus Disease 2019 (COVID-19), and Coronavirus Disease 2019 (COVID-19) Associated Acute...
-
Product Insights
NewAmyloid Beta A4 Protein – Drugs In Development, 2024
The Amyloid Beta A4 Protein pipeline drugs market research report outlays comprehensive information on the Amyloid Beta A4 Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Infectious Disease, and Ophthalmology which include indications of Alzheimer's Disease, Parkinson's Disease, Type 2 Diabetes, Amyloidosis, Coronavirus Disease 2019 (COVID-19), Infectious Disease, Glaucoma, and Age...
-
Product Insights
NewAmine Oxidase [Flavin Containing] B – Drugs In Development, 2024
The Amine Oxidase [Flavin Containing] B pipeline drugs market research report outlays comprehensive information on the Amine Oxidase [Flavin Containing] B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Immunology, and Genetic Disorders which include indications of Parkinson's Disease, Alzheimer's Disease, Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Coronavirus Disease 2019...
-
Product Insights
NewProstaglandin E2 Receptor EP1 Subtype – Drugs In Development, 2024
The Prostaglandin E2 Receptor EP1 Subtype pipeline drugs market research report outlays comprehensive information on the Prostaglandin E2 Receptor EP1 Subtype targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Gastrointestinal, and Infectious Disease which include indications of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), Raynauds Disease, Post-Operative Pain, Pain, Oral Mucositis, and...
-
Product Insights
NewPoly [ADP Ribose] Polymerase 2 – Drugs In Development, 2024
The Poly [ADP Ribose] Polymerase 2 pipeline drugs market research report outlays comprehensive information on the Poly [ADP Ribose] Polymerase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Undisclosed which include indications of Ovarian Cancer, Solid Tumor, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Pneumonia, and Unspecified. It also reviews key...
-
Product Insights
NewInterleukin 6 – Drugs In Development, 2024
The Interleukin 6 pipeline drugs market research report outlays comprehensive information on the Interleukin 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Infectious Disease, and Ophthalmology which include indications of Rheumatoid Arthritis, Inflammation, Oncology, Lung Cancer, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Diabetic Macular Edema, and Uveitis. It...
-
Product Insights
NewF2R Receptor – Drugs In Development, 2024
The F2R Receptor pipeline drugs market research report outlays comprehensive information on the F2R Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Cardiovascular, Central Nervous System, and Gastrointestinal which include indications of Asthma, Unspecified Respiratory Disorders, Thrombosis, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Migraine, Unspecified Neurologic Disorders, Inflammatory Bowel Disease, and Metabolic Dysfunction-Associated Steatohepatitis...